Total Payments
$26,960
2024 Payments
$336.64
Companies
29
Transactions
377
Medicare Patients
2,457
Medicare Billing
$271,548
Payment Breakdown by Category
Other$8,625 (32.0%)
Food & Beverage$8,461 (31.4%)
Consulting$6,893 (25.6%)
Travel$2,836 (10.5%)
Education$85.98 (0.3%)
Gifts$59.40 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,625 | 6 | 32.0% |
| Food and Beverage | $8,461 | 353 | 31.4% |
| Consulting Fee | $6,893 | 3 | 25.6% |
| Travel and Lodging | $2,836 | 9 | 10.5% |
| Education | $85.98 | 5 | 0.3% |
| Gift | $59.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $8,822 | 18 | $0 (2019) |
| Corcept Therapeutics | $7,047 | 84 | $0 (2023) |
| Novo Nordisk Inc | $5,302 | 33 | $0 (2024) |
| Lilly USA, LLC | $1,688 | 77 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $717.31 | 38 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $698.09 | 5 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $555.67 | 13 | $0 (2019) |
| Mannkind Corporation | $267.29 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $260.41 | 25 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $250.00 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $336.64 | 14 | Lilly USA, LLC ($138.45) |
| 2023 | $622.14 | 28 | Lilly USA, LLC ($319.83) |
| 2022 | $1,245 | 54 | Corcept Therapeutics ($413.12) |
| 2021 | $1,032 | 42 | Corcept Therapeutics ($563.63) |
| 2020 | $1,598 | 35 | Corcept Therapeutics ($1,272) |
| 2019 | $2,340 | 58 | AstraZeneca Pharmaceuticals LP ($1,007) |
| 2018 | $10,547 | 64 | Novo Nordisk Inc ($4,819) |
| 2017 | $9,240 | 82 | AstraZeneca Pharmaceuticals LP ($7,723) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/14/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 05/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 02/14/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Diabetes | ||||||
| 01/10/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Diabetes | ||||||
| 08/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Diabetes | ||||||
| 08/09/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Diabetes | ||||||
| 06/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes | ||||||
| 06/12/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/07/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/31/2023 | Lilly USA, LLC | JARDIANCE (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Diabetes | ||||||
| 05/23/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 598 | 1,042 | $115,253 | $74,751 |
| 2022 | 9 | 643 | 1,116 | $119,011 | $76,206 |
| 2021 | 9 | 614 | 1,043 | $107,327 | $70,083 |
| 2020 | 9 | 602 | 970 | $82,004 | $50,507 |
Total Patients
2,457
Total Services
4,171
Medicare Billing
$271,548
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 301 | $47,971 | $31,527 | 65.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 162 | $36,112 | $23,856 | 66.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $11,777 | $6,322 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 71 | $8,302 | $5,234 | 63.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 44 | 113 | $4,727 | $3,133 | 66.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 169 | 289 | $2,890 | $2,428 | 84.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 40 | $2,901 | $1,874 | 64.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 32 | $574.21 | $377.89 | 65.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 342 | $57,027 | $36,149 | 63.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 86 | 104 | $23,573 | $16,036 | 68.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 50 | 50 | $13,972 | $9,150 | 65.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 95 | $10,980 | $7,047 | 64.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 46 | 110 | $4,725 | $3,185 | 67.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 43 | $3,175 | $2,102 | 66.2% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2022 | 20 | 20 | $1,581 | $1,091 | 69.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 181 | 309 | $3,180 | $915.12 | 28.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 43 | $798.56 | $532.94 | 66.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 158 | 315 | $51,249 | $34,250 | 66.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 60 | 77 | $17,423 | $11,017 | 63.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 49 | 49 | $13,597 | $9,251 | 68.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 75 | 114 | $13,229 | $8,775 | 66.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 38 | 89 | $3,910 | $2,681 | 68.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 41 | $2,914 | $1,938 | 66.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 190 | 308 | $3,080 | $924.00 | 30.0% |
| 95249 | Continuous monitoring of glucose in tissue fluid using sensor under skin | Office | 2021 | 14 | 15 | $1,148 | $806.45 | 70.3% |
About Dr. Jerold Share, M.D
Dr. Jerold Share, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851350508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerold Share, M.D has received a total of $26,960 in payments from pharmaceutical and medical device companies, with $336.64 received in 2024. These payments were reported across 377 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,625).
As a Medicare-enrolled provider, Share has provided services to 2,457 Medicare beneficiaries, totaling 4,171 services with total Medicare billing of $271,548. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Washington, DC
- Active Since 03/21/2006
- Last Updated 12/31/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851350508
Products in Payments
- Korlym (Drug) $7,047
- FARXIGA (Drug) $6,821
- Victoza (Drug) $4,927
- BYDUREON (Drug) $1,850
- UNITHROID (Drug) $750.32
- t-slim insulin pump (Device) $698.09
- JARDIANCE (Drug) $544.40
- MOUNJARO (Drug) $467.69
- SOLIQUA 100/33 (Drug) $350.00
- TRULICITY (Drug) $324.53
- INVOKANA (Drug) $300.99
- AFREZZA (Drug) $267.29
- Ozempic (Drug) $260.50
- JANUVIA (Drug) $260.41
- RECORLEV (Drug) $150.37
- HUMULIN (Drug) $139.18
- Repatha (Biological) $131.10
- Androgel (Drug) $116.97
- BAQSIMI (Drug) $112.59
- TOUJEO (Drug) $111.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Washington
Natasa Janicic-Kahric
Endocrinology, Diabetes & Metabolism — Payments: $343,214
Endocrinology, Diabetes & Metabolism $343,214
Robert Ratner, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $90,184
Endocrinology, Diabetes & Metabolism $90,184
Adline Ghazi, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $67,397
Endocrinology, Diabetes & Metabolism $67,397
Leonard Wartofsky, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $66,424
Endocrinology, Diabetes & Metabolism $66,424
Meeta Sharma, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $61,957
Endocrinology, Diabetes & Metabolism $61,957
Joseph Verbalis
Endocrinology, Diabetes & Metabolism — Payments: $44,007
Endocrinology, Diabetes & Metabolism $44,007